Brief: Shockwave Medical And Genesis MedTech Obtain Regulatory Approval In China For Intravascular Lithotripsy
23/05/2022 12:43
May 23 (Reuters) - Shockwave Medical Inc SWAV.O :
* SHOCKWAVE MEDICAL AND GENESIS MEDTECH OBTAIN REGULATORY
APPROVAL
IN CHINA FOR INTRAVASCULAR LITHOTRIPSY
Source text for Eikon: ID:nGNX98BT9Y
Further company coverage: SWAV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shockwave Medical
See all newsSarepta Therapeutics gains on S&P MidCap inclusion
Brief: Sarepta Therapeutics Set To Join S&P Midcap 400
Brief: Shockwave Medical Required Waiting Period For Johnson & Johnson Merger Expired On May 20
Shockwave Medical Inc reports results for the quarter ended in January - Earnings Summary
Brief: Shockwave Medical Q1 EPS USD 1.44